
Resident patentees whose AY 2026-27 return falls in the audit category covered by CBDT Circular No. 07/2026 must file Form 3CFA by 21 November 2026. The circular, issued on 28 September 2026, extended the section 139(1) due date from 31 October 2026 to 21 November 2026 for companies and non-company persons whose accounts are auditable under the Income-tax Act or another law, excluding section 92E cases.
Section 115BBF(3) of the Income-tax Act, 1961 links the patent-royalty option to the section 139(1) due date. Rule 5G prescribes Form 3CFA. The option applies to royalty from a patent developed and registered in India, the claimant must be resident in India and recorded as the true and first inventor on the patent register, and at least 75% of the invention-development expenditure must have been incurred in India. Qualifying royalty is taxed at 10%, with no expenditure or allowance deductible against it.
Consideration for sale of a patented product, capital-gains consideration and other receipts outside the statutory royalty definition do not qualify. If the option is used and the income is not offered under the regime in any of the next five assessment years, the benefit is denied for five subsequent assessment years.
The 21 November deadline applies only to patentees in the audit category covered by the circular, those with a 30 November due date under section 92E must follow that date. The eligibility conditions, residence, inventor identity, 75% domestic expenditure, are tightly drawn, excluding assignees and licensees who are not the true and first inventor. Taxpayers with bundled payments must allocate between qualifying royalty and excluded consideration such as product sales or capital gains. The five-year continuity rule means a single year of non-compliance forfeits the benefit for five assessment years, making consistent annual filing essential.
Source: taxguru.in
This brief was synthesised by AI from the source linked above. Methodology and corrections.